RecruitingNot ApplicableNCT05837286

Conservative Treatment of Trigger Finger

Conservative Treatment of Trigger Finger: Outcomes of a Randomized Controlled Trial


Sponsor

Cedars-Sinai Medical Center

Enrollment

146 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study is to analyze the effectiveness of a nighttime extension orthosis after receiving a cortisone injection for the treatment of trigger finger to improve pain and restore functional outcomes. The investigators hypothesize that the extension orthosis will improve pain and functional outcomes compared to those without a digital night extension orthosis in those with trigger finger at 12 weeks from the injection.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This retrospective study examines the effectiveness of conservative (non-surgical) treatment for trigger finger — a condition officially known as stenosing flexor tenosynovitis — in which a finger gets stuck in a bent position and must be forcibly straightened, sometimes with a painful "click." It occurs when inflammation narrows the tendon sheath around the finger's flexor tendon. Conservative treatment typically involves cortisone injections, splinting, and exercises. The study reviews medical records to understand how well these approaches work across a real-world patient population. Adults aged 18 and older who have a diagnosis of trigger finger and have received at least one cortisone injection in the affected finger are eligible for records review. Patients with rheumatoid arthritis, a history of traumatic hand injury, or cognitive problems preventing proper consent are excluded, as are non-English speakers and those who have opted out of research participation. Trigger finger is one of the most common hand conditions treated in outpatient orthopedic and primary care settings, yet the long-term success rates of conservative treatment — and the factors that predict who eventually needs surgery — are incompletely understood. By analyzing outcomes in a large real-world cohort, this study can help clinicians counsel patients more accurately about what to expect and when to escalate to surgical intervention.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOval-8 ® Orthosis

The experimental group will consist of receiving a PIP joint on the day they receive their cortisone injection. The Oval-8 ® will be issued to the subject by an Occupational Therapist to ensure correct fit and comfort as well as given written instructions for night use. The orthosis will be worn at night for 6-week duration. Participants will have 1 follow up phone call or email at the 6-week mark and then 1 follow up phone call or email at the 12 week mark by a member of the research team from the time they received their cortisone injection where the time for resolution of trigger finger symptoms, VAS (Visual Analogue Scale), subjective questionnaire and QuickDASH scores will all be recorded in their medical research file.

OTHERCortisone injection only

The control group will receive a cortisone injection and be instructed to move their fingers normally


Locations(2)

Cedars-Sinai Medical Center Outpatient Rehabilitation Hand Clinic

Los Angeles, California, United States

Cedars-Sinai Medical Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05837286


Related Trials